"Dead Calm" was a great movie.
It also seems an apt
"Dead Calm" was a great movie.
It also seems an apt description of where we are at 7:11 pm on 8/8/2025.
I think what unites all of us is a bedrock belief in the unmatched efficacy and safety of Leronlimab in scads of diseases. A veritable typhoon of life-saving potential!
Then I look at our share price.
So I read the message boards. And while some investors are over the moon with optimism over Cytodyn's management . . . if I let the share price of the last 5 years speak for me, I am less than enthused. Some believe the past/current silence could only mean an NDA is in effect, some believe the shelf offering and running out of cash and the lack of a new lease in Vancouver prove the promised land is just over the horizon . . . but doesn't good news generally leak? Maybe not, maybe CYDY runs an airtight ship.
But without information? To me, this continued silence could also sound like incompetence or indifference.
Not bashing, still all in. As in EVERYTHING I have is all in (except the mortgage). But when our best results - when those mind-blowing TNBC results are due to the previous management and we're just now on the front end of a study that may not yield results for a year?
Dead calm. Hoping for a partnership to put some wind in our sails, but failing that? Enough said, but the captain sets the course.
14
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
KPN's Strategic Share Buyback Initiative KPN is making notable strides with its €250 million share buyback program. Recently, the company repurchased a significant amount of its ordinary shares from March 24 to March 28. This specific buyback involved 2,020,000 shares, purchased at an average price of €3.84 per share, totaling approximately €7.8 million. These...
Continue Reading
Fabrinet's Market Share of Short Interest Fabrinet (FN) has seen a notable reduction in the short percent of float, declining by 8.9% since its last report. Recently, the company disclosed that approximately 1.89 million shares have been sold short, accounting for 7.27% of the total shares available for trading. Given the current trading volume, it is estimated that...
Continue Reading
Aduna and Comviva: A Strategic Partnership in Network APIs In an exciting development, two key players in the technology and telecom sectors, Aduna and Comviva, have announced a strategic partnership designed to drive the adoption and monetization of network APIs on a global scale. This collaboration promises to simplify and enhance the way enterprises interact with...
Continue Reading
Insights on Future Health and Wellness Trends Brian Gould is a prominent voice in the health and wellness community. As the CEO of TruLife Distribution, he possesses a unique insight into the evolving landscape of wellness and health trends for the upcoming years. With an ever-increasing focus on personal well-being, it's exciting to learn what trends he anticipates...
Continue Reading
Energy Dome Collaborates with Alliant Energy Energy Dome, known for its innovative CO2 Battery technology, has made headlines by signing a significant contract for the Columbia Energy Storage Project with Alliant Energy. This partnership marks a crucial milestone in the development of long-duration energy storage solutions in the U.S. U.S. Department of Energy...
Continue Reading